PharmaShots | Incisive News in 3 Shots

Subscribe Now

QBiotics Group

QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs

QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs

November 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us